Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross Sectional Study

    GRANDFILS N, DETOURNAY B, ATTALI C, JOLY D, SIMON D, VERGES B, TOUSSI M, BRIAND Y, DELAITRE O

    Int J Endocrinol ; 2013;2013:640632

  • Pharmaco-EpidĂ©miologie

    Facteurs associĂ©s Ă  l’hospitalisation des personnes diabĂ©tiques adultes en France Entred 2007

    ASSOGBA F , PENFORNIS F , DETOURNAY B, LECOMTE  P, BOURDEL-MARCHASSON I, DRUET C , WEILL A , FAGOT-CAMPAGNA A, FOSSE-EDORH S

    BEH ; 2013;37-38:454-463

  • Économie de la santĂ©

    Aspects économiques du diabÚte en France : quelles évolutions?

    DETOURNAY B

    Med Mal Metab ; 2013;7(3):224-227

  • Pharmaco-EpidĂ©miologie

    Use of vildagliptin in management of type 2 diabetes : effectiveness, treatment persistence and safety from the 2-year real-life VILDA study

    SIMON D, DETOURNAY B, ESCHWEGE E, BOUEE S, BRINGER J, ATTALI C, DEJAGER S

    Diabetes Ther ; 2014;5(1):207-224

  • Pharmaco-EpidĂ©miologie

    Types 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France

    FOSSE-EDORH S, FAGOT-CAMPANA A, DETOURNAY B, BIHAN H, GAUTIER A, DALICHAMPT M, DRUET C

    Diabetes Metab ; 2014;40(2):143-50